HK Stock Market Move | China Overseas (00688) rose nearly 3%, with the total property sales amount for the first four months increasing by 13.7% year-on-year. The sales trend is improving marginally.
China Overseas Development (00688) rises nearly 3%, as of the time of writing, it has increased by 2.58%, standing at 16.33 HKD, with a transaction volume of 634 million HKD.
CHINA OVERSEAS (00688) rose nearly 3%, as of the time of writing, it rose by 2.58% to HKD 16.33, with a turnover of HKD 6.34 billion.
In terms of news, on May 8, CHINA OVERSEAS announced that in April 2026, the contract property sales of China Overseas series companies amounted to approximately RMB 24.191 billion, a year-on-year increase of 20.0%; the corresponding sales area was approximately 802,100 square meters, a year-on-year increase of 9.0%. From January to April 2026, the cumulative contract property sales of China Overseas series companies amounted to approximately RMB 75.711 billion, a year-on-year increase of 13.7%; the corresponding cumulative sales area was approximately 2.6192 million square meters, a year-on-year decrease of 10.6%.
EB SECURITIES pointed out that CHINA OVERSEAS has a clear advantage in property development, with the "China Overseas LivingOS system" fully implementing the characteristics of "safe, comfortable, green, and intelligent" homes. In the period from January to April 2026, the company's sales amount of RMB 75.71 billion (up 13.7% year-on-year) remained at the forefront of the industry, with an average selling price of RMB 28,900 per square meter (up 27.1% year-on-year), and the sales trend improving marginally. The bank believes that the real estate industry is still at the bottoming stage, with urban and regional differentiation continuing to deepen, the company's leading position is stable, and sales are improving marginally.
Related Articles

PCPD (00432) plans to issue $500 million guaranteed notes due in 2029 with a coupon rate of 7.5%.

SBP GROUP (01177) reached an exclusive strategic cooperation agreement with GlaxoSmithKline.

HK SH ALLIANCE (01001) subsidiary is submitting a bid for the construction of a BOT project for a large building in Tsing Yi, Hong Kong. The contract period is for 30 years.
PCPD (00432) plans to issue $500 million guaranteed notes due in 2029 with a coupon rate of 7.5%.

SBP GROUP (01177) reached an exclusive strategic cooperation agreement with GlaxoSmithKline.

HK SH ALLIANCE (01001) subsidiary is submitting a bid for the construction of a BOT project for a large building in Tsing Yi, Hong Kong. The contract period is for 30 years.






